Uploaded by FinancialNewsOnline on Jan 26, 2011
Abbott Labs (NYSE:ABT) reported Q4 EPS of $1.30, a penny above the consensus estimate of $1.29 per share. Revenue rose 13.4% to $9.97 billion, above the Street estimate of $9.89 billion. Sales of Humira rose 13% to $1.88 billion.
The company said it sees ongoing full-year 2011 EPS rising double digits over 2010. This equates to a range of $4.54-$4.64, vs. estimates of $4.63. Abbott said its 2011 outlook reflects the incremental impact of costs associated with U.S. Healthcare Reform, as well as the impact of European austerity measures.
Chairman and CEO Miles White said, "Despite a very challenging environment, 2010 was another productive year for Abbott, resulting in strong financial performance. We also took decisive long-term strategic actions to expand our emerging markets presence and late-stage pipeline to better position Abbott for sustainable long-term growth. We anticipate delivering another year of double-digit ongoing earnings-per-share growth in 2011."
Abbott also said that it would be streamlining its U.S. pharmaceutical operations which would result in 1,900 job cuts representing 2% of its total workforce.
-
3 likes, 0 dislikes
-
As Seen On:
World News Update
1:24
Abbott Beats By A Penny, Sees Better-Than-Expected FY EPSby FinancialNewsOnline42 views
1:12
Health Care Sector Report: January 26th, 2011by FinancialNewsOnline34 views
0:38
Bayer Determined to Enforce Intellectual Property Rights After Abbott Defeat - ADRs Higherby FinancialNewsOnline16 views
0:51
Sector Update- Health Care - January 12, 2011by FinancialNewsOnline31 views
3:19
2011 Midwest Gala / Abbott Labsby weizmannusa142 views
2:20
Are Big Pharma Execs Above the Law?by CheatingCulture354 views
5:34
Michael Abad - Abbott Laboratoriesby VidPR3,836 views
2:34
Unethical Pharma Ad: Niaspan from Abbott Labsby morepuppies3,562 views
0:59
News Update: Abbott Laboratories To Cut 3,000 Jobs Following Solvay SA Unit Acquisitionby TradeTheTrend1,365 views
2:58
Abbott A Promise for Lies - Hannover Demo 07. März 2011by tnpkblnn1,292 views
5:38
Tony Abbott emissions plan 1 OF 2.by australianews1,169 views
1:00
Parody: AHF Slams Abbott AIDS Drug Pricing (1/27/09)by aidshealth3,020 views
1:03
Company Profile: Abbott Laboratories (NYSE:ABT)by TradeTheTrend2,295 views
0:35
Abbott Labs - Gain Plus. Spot "Play Calendar"by natorola2,438 views
0:55
Frisbee with Phoebe the Wonderdog in Abbott Parkby danieljhale109 views
0:37
Abbott A promise for liesby Apromiseforlies3,503 views
2:56
Newly Discovered Biomarker Predicts Cancer Growthby VOAvideo387 views
0:34
Abbott Labs recalls Similac baby formulaby kxan32,879 views
1:55
Fake IV & Glucose Fluids Seized at Jodhpur City Hospitalby NTDTV455 views
1:44
Analyst Insight: Abbott Laboratories Expects 2H 2010 to Show Boosted Organic Growthby TradeTheTrend404 views
- Loading more suggestions...
Link to this comment:
All Comments (0)